C. Bale

1.1k total citations
10 papers, 624 citations indexed

About

C. Bale is a scholar working on Pulmonary and Respiratory Medicine, Health and Oncology. According to data from OpenAlex, C. Bale has authored 10 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Health and 4 papers in Oncology. Recurrent topics in C. Bale's work include Advanced Breast Cancer Therapies (4 papers), Immune responses and vaccinations (4 papers) and Vaccine Coverage and Hesitancy (4 papers). C. Bale is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Immune responses and vaccinations (4 papers) and Vaccine Coverage and Hesitancy (4 papers). C. Bale collaborates with scholars based in United Kingdom, Guinea-Bissau and Gambia. C. Bale's co-authors include M.‐L. Garly, Cesário Martins, Peter Aaby, Amabélia Rodrigues, Ida Maria Lisse, Henrik Ravn, Andreas Andersen, H.C. Whittle, Angela Casbard and Robert H. Jones and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and The Journal of Infectious Diseases.

In The Last Decade

C. Bale

9 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Bale United Kingdom	7	287	227	207	160	160	10	624
Christopher Robertson United Kingdom	9	56 0.2×	41 0.2×	103 0.5×	120 0.8×	117 0.7×	12	490
Jimmy Hwang United States	14	48 0.2×	10 0.0×	76 0.4×	144 0.9×	153 1.0×	26	631
Leah Isakov United States	10	280 1.0×	13 0.1×	103 0.5×	151 0.9×	99 0.6×	16	515
Alessandra Barca Italy	15	74 0.3×	9 0.0×	205 1.0×	275 1.7×	88 0.6×	35	893
Saoirse Dolly United Kingdom	13	76 0.3×	14 0.1×	179 0.9×	330 2.1×	107 0.7×	32	725
Merav Ben‐Yehoyada Israel	11	55 0.2×	92 0.4×	14 0.1×	137 0.9×	66 0.4×	17	793
Eduardo B. Martins United States	17	114 0.4×	15 0.1×	44 0.2×	50 0.3×	1.1k 6.8×	42	1.4k
Vilas D. Nasare India	13	104 0.4×	47 0.2×	19 0.1×	117 0.7×	243 1.5×	32	509
Yin‐Chu Chien Taiwan	8	72 0.3×	20 0.1×	53 0.3×	363 2.3×	328 2.0×	10	726
Ramou Njie Gambia	14	31 0.1×	30 0.1×	25 0.1×	69 0.4×	693 4.3×	26	870

Countries citing papers authored by C. Bale

Since Specialization

Citations

This map shows the geographic impact of C. Bale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bale more than expected).

Fields of papers citing papers by C. Bale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bale. The network helps show where C. Bale may publish in the future.

Co-authorship network of co-authors of C. Bale

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bale. A scholar is included among the top collaborators of C. Bale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bale. C. Bale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Pearson‐Stuttard, Jonathan, Rebecca Sloan, Thomas Porter, et al.. (2024). Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in Wales. PharmacoEconomics. 43(2). 191–207.

Howell, Sacha J., Angela Casbard, Margherita Carucci, et al.. (2022). Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial. The Lancet Oncology. 23(7). 851–864. 87 indexed citations

Jones, Robert H., Angela Casbard, Margherita Carucci, et al.. (2022). Fulvestrant plus capivasertib versus fulvestrant plus placebo after relapse or progression on an aromatase inhibitor in metastatic, estrogen receptor–positive breast cancer (FAKTION): Overall survival and updated progression-free survival data with enhanced biomarker analysis.. Journal of Clinical Oncology. 40(16_suppl). 1005–1005. 4 indexed citations

Jones, Robert H., Angela Casbard, Margherita Carucci, et al.. (2020). Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial. The Lancet Oncology. 21(3). 345–357. 159 indexed citations

Fuller, Claire, et al.. (2019). A retrospective comparison of frontline platinum in non-squamous non-small-cell lung cancer in North Wales over 9 years. Lung Cancer. 127. S32–S32. 1 indexed citations

Jones, Robert H., Margherita Carucci, Angela Casbard, et al.. (2019). Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION): A randomized, double-blind, placebo-controlled, phase II trial.. Journal of Clinical Oncology. 37(15_suppl). 1005–1005. 27 indexed citations

Martins, Cesário, M.‐L. Garly, C. Bale, et al.. (2014). Measles Virus Antibody Responses in Children Randomly Assigned to Receive Standard-Titer Edmonston-Zagreb Measles Vaccine at 4.5 and 9 Months of Age, 9 Months of Age, or 9 and 18 Months of Age. The Journal of Infectious Diseases. 210(5). 693–700. 20 indexed citations

Aaby, Peter, Cesário Martins, M.‐L. Garly, et al.. (2010). Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ. 341(nov30 2). c6495–c6495. 227 indexed citations

Martins, Cesário, M.‐L. Garly, C. Bale, et al.. (2008). Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ. 337(jul24 2). a661–a661. 60 indexed citations

10.

Garly, M.‐L., Cesário Martins, C. Bale, et al.. (1999). Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy. International Journal of Epidemiology. 28(2). 347–352. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact